Transcatheter heart valve failure: A systematic review

European Heart Journal

Volumn 36, Issue 21, 2015, Pages 1306-1327

  Mylotte, Darren ^a,b   Andalib, Ali ^a   Thériault Lauzier, Pascal ^a   Dorfmeister, Magdalena ^c   Girgis, Mina ^a   Alharbi, Waleed ^a   Chetrit, Michael ^a   Galatas, Christos ^a   Mamane, Samuel ^a   Sebag, Igal ^d   Buithieu, Jean ^a   Bilodeau, Luc ^a   De Varennes, Benoit ^a   Lachapelle, Kevin ^a   Lange, Ruediger ^c   Martucci, Giuseppe ^a   Virmani, Renu ^e   Piazza, Nicolo ^a,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d MCGILL UNIVERSITY   (Canada)

^e CVPATH INSTITUTE   (United States)

Author keywords

Aortic stenosis; Heart valve failure; Prosthetic valve endocarditis; Transcatheter aortic valve implantation; Transcatheter heart valve failure

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL EMBOLISM; HEART VALVE PROSTHESIS; HUMAN; MITRAL VALVE DISEASE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHESIS THROMBOSIS; PROSTHETIC VALVE DYSFUNCTION; PROSTHETIC VALVE ENDOCARDITIS; RESUSCITATION; STRUCTURAL HEART VALVE FAILURE; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSCATHETER HEART VALVE COMPRESSION; TRANSCATHETER HEART VALVE EMBOLISM; TRANSCATHETER HEART VALVE FAILURE; TRANSCATHETER HEART VALVE PROSTHETIC VALVE ENDOCARDITIS; AGED; AORTIC VALVE STENOSIS; EMBOLISM; ENDOCARDITIS; FEMALE; GRAFT OCCLUSION, VASCULAR; GRAM-POSITIVE BACTERIAL INFECTIONS; HISTOPLASMOSIS; MALE; MIDDLE AGED; PROSTHESIS FAILURE; RISK FACTOR; VERY ELDERLY;

ANTIINFECTIVE AGENT;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; AORTIC VALVE STENOSIS; EMBOLISM; ENDOCARDITIS; FEMALE; GRAFT OCCLUSION, VASCULAR; GRAM-POSITIVE BACTERIAL INFECTIONS; HEART VALVE PROSTHESIS; HISTOPLASMOSIS; HUMANS; MALE; MIDDLE AGED; PROSTHESIS FAILURE; RISK FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84937722424     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu388     Document Type: Article

References (117)

1. Mylotte D, Osnabrugge RL, Windecker S, Lefevre T, de Jaegere P, Jeger R, Wenaweser P, Maisano F, Moat N, Sondergaard L, Bosmans J, Teles RC, Martucci G, Manoharan G, Garcia E, Van Mieghem NM, Kappetein AP, Serruys PW, Lange R, Piazza N. Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. J Am Coll Cardiol 2013;62:210-219.
2. Lange R, Bleiziffer S, Mazzitelli D, ElhmidiY, Opitz A, Krane M, Deutsch MA, Ruge H, Brockmann G, Voss B, Schreiber C, Tassani P, Piazza N. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future. J Am Coll Cardiol 2011;59:280-287.
3. Wenaweser P, Stortecky S, Schwander S, Heg D, Huber C, Pilgrim T, Gloekler S, O'Sullivan CJ, Meier B, Juni P, Carrel T, Windecker S. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J 2013;34:1894-1905.
4. Kodali SK, Williams MR, Smith CR, Svensson LG,Webb JG, Makkar RR, FontanaGP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, SzetoWY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A,Wang D, Akin JJ, Anderson WN, Leon MB. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366:1686-1695.
5. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696-1704.
6. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009;137:82-90.
7. Rahimtoola SH. Choice of prosthetic heart valve in adults an update. J Am Coll Cardiol 2010;55:2413-2426.
8. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000;36:1152-1158.
9. Stassano P, Di Tommaso L, Monaco M, Iorio F, Pepino P, Spampinato N, Vosa C. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol 2009;54: 1862-1868.
10. Moher D, Liberati A,Tetzlaff J, AltmanDG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151: 264-269, w64.
11. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodes-Cabau J, Vranckx P,Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. EuroIntervention 2012;8:782-795.
12. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Muller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369-2413.
13. Dwyer HA, Matthews PB, Azadani A, Ge L, Guy TS, Tseng EE. Migration forces of transcatheter aortic valves in patients with noncalcific aortic insufficiency. J Thorac Cardiovasc Surg 2009;138:1227-1233.
14. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, Feindel CM, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson M, Thompson CR, Wood D, Toggweiler S, Gurvitch R, Lichtenstein SV, Doyle D, DeLarochelliere R, Teoh K, Chu V, Bainey K, Lachapelle K, Cheema A, Latter D, Dumesnil JG, Pibarot P, Horlick E. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol 2012;60:1864-1875.
15. Thomas M, Schymik G,Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR,Wendler O. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425-433.
16. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrie D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705-1715.
17. WongDR, Boone RH, Thompson CR, AllardMF, Altwegg L, Carere RG, Cheung A, Ye J, Lichtenstein SV, Ling H,Webb JG. Mitral valve injury late after transcatheter aortic valve implantation. J Thorac Cardiovasc Surg 2009;137:1547-1549.
18. Comoglio C, Boffini M, El Qarra S, Sansone F, D'Amico M, Marra S, Rinaldi M. Aortic valve replacement and mitral valve repair as treatment of complications after percutaneous core valve implantation. J Thorac Cardiovasc Surg 2009;138:1025-1027.
19. Carnero-Alcazar M, Maroto Castellanos LC, Carnicer JC, Rodriguez Hernandez JE. Transapical aortic valve prosthetic endocarditis. Interact Cardiovasc Thorac Surg 2010;11:252-253.
20. Santos M, Thiene G, Sievers HH, Basso C. Candida endocarditis complicating transapical aortic valve implantation. Eur Heart J 2011;32:2265.
21. Gotzmann M, Mugge A. Fatal prosthetic valve endocarditis of the CoreValve ReValving system. Clin Res Cardiol 2011;100:715-717.
22. Head SJ, Dewey TM, Mack MJ. Fungal endocarditis after transfemoral aortic valve implantation. Catheter Cardiovasc Interv 2011;78:1017-1019.
23. Chrissoheris MP, Ferti A, Spargias K. Early prosthetic valve endocarditis complicating repeated attempts at CoreValve implantation. J Invasive Cardiol 2011;23: E291-E292.
24. Rafiq I, Parthasarathy H, Tremlett C, Freeman LJ, Mullin M. Infective endocarditis caused by Moraxella nonliquefaciens in a percutaneous aortic valve replacement. Cardiovasc Revasc Med 2011;12:184-186.
25. Castiglioni A, Pozzoli A, Maisano F, Alfieri O. Endocarditis after transfemoral aortic valve implantation in a patient with Osler-Weber-Rendu syndrome. Interact Cardiovasc Thorac Surg 2012;15:553-554.
26. Garcia-Pardo H, Revilla A, SevillaT, Lopez J, Ortiz C, San RomanJA. Staphylococcus aureus endocarditis on transcatheter aortic valves. Rev Esp Cardiol (Engl Ed) 2012; 65:771-773.
27. Loh PH, Bundgaard H, Ndergaard SL. Infective endocarditis following transcatheter aortic valve replacement: diagnostic and management challenges. Catheter Cardiovasc Interv 2013;81:623-627.
28. Puls M, Eiffert H, Hunlich M, Schondube F, Hasenfuss G, Seipelt R, Schillinger W. Prosthetic valve endocarditis after transcatheter aortic valve implantation: the incidence in a single-centre cohort and reflections on clinical, echocardiographic and prognostic features. EuroIntervention 2013;8:1407-1418.
29. Seeburger J, Weiss G, Borger MA, Mohr FW. Structural valve deterioration of a Corevalve prosthesis 9 months after implantation. Eur Heart J 2013;34:1607.
30. Citro R, Mirra M, Baldi C, Prota C, Palumbo B, Piscione F, La Canna G. Concomitant dynamic obstruction and endocarditis after "valve in valve" TAVI implantation. Int J Cardiol 2013;167:e27-e29.
31. Orban M, Sinnecker D, Mair H, Nabauer M, Kupatt C, Schmitz C, Massberg S, Laugwitz KL, Barthel P. Transcatheter aortic-valve endocarditis confirmed by transesophageal echocardiography. Circulation 2013;127:e265-e266.
32. Zytowski M, Erb M, Albes JM, Hartrumpf M. Infective endocarditis 4 months after transapical aortic valve implantation with Edwards SAPIEN XT. Eur J Cardiothorac Surg 2013;44:769.
33. Loeser H, Wittersheim M, Puetz K, Friemann J, Buettner R, FriesJW. Potential complications of transcatheter aortic valveimplantation (TAVI)-an autopsy perspective. Cardiovasc Pathol 2013;22:319-323.
34. Wilbring M, Tugtekin SM, Matschke K, Kappert U. Surgery for Fulminant Prosthetic Valve Endocarditis after Transapical Transcatheter Aortic Valve-in-Valve Implantation. Thorac Cardiovasc Surg 2013;62:80-82.
35. Aung T, Poon K, Horvath R, Coulter C, Walters DL. A case series of medically managed infective endocarditis after transcatheter aortic valve replacement. Scand J Infect Dis 2013;45:489-493.
36. Hirnle G, Holzhey D, Borger M, Mohr FW. Infective mitral valve endocarditis after transapical aortic valve implantation. Interact Cardiovasc Thorac Surg 2013;16: 394-395.
37. Seok Koh Y, Hyoung Moon M, Hyun Jo K,Wook Kim H. Infective endocarditis in transcatheter aortic valve implantation. Eur J Cardiothorac Surg 2013;45:582.
38. Drews T, Pasic M, Buz S, Unbehaun A, Dreysse S, Kukucka M, Mladenow A, Hetzer R. Transapical aortic valve implantation after previous mitral valve surgery. J Thorac Cardiovasc Surg 2011;142:84-88.
39. Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, Hetzer R. Transapical aortic valve implantation after previous aortic valve replacement: clinical proof of the "valve-in-valve" concept. J Thorac Cardiovasc Surg 2011;142:270-277.
40. Nietlispach F,Webb JG, Ye J, Cheung A, Lichtenstein SV, Carere RG, Gurvitch R, Thompson CR, Ostry AJ, Matzke L, Allard MF. Pathology of transcatheter valve therapy. JACC Cardiovasc Interv 2012;5:582-590.
41. Bozdag Turan I, Kische S, D'Ancona G, Nienaber CA, Ince H. Suspected endocarditis after CoreValve implantation: a word of caution. Anadolu Kardiyol Derg 2013; 13:395-396.
42. Raschpichler M, Seeburger J, Strasser RH, Misfeld M. Corevalve prosthesis causes anterior mitral leaflet perforation resulting in severe mitral regurgitation and subsequent endocarditis. Eur Heart J 2014;35:1587.
43. Genereux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 2012; 59:2317-2326.
44. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997;277:1794-1801.
45. Seto TB, Kwiat D, Taira DA, Douglas PS, Manning WJ. Physicians' recommendations to patients for use of antibiotic prophylaxis to prevent endocarditis. JAMA 2000;284:68-71.
46. Piazza N, Marra S, Webb J, D'Amico M, Rinaldi M, Boffini M, Comoglio C, Scacciatella P, Kappetein AP, de Jaegere P, Serruys PW. Two cases of aneurysm of the anterior mitral valve leaflet associated with transcatheter aortic valve endocarditis: a mere coincidence? J Thorac Cardiovasc Surg 2010;140:e36-e38.
47. Piper C, Hetzer R, Korfer R, Bergemann R, Horstkotte D. The importance of secondary mitral valve involvement in primary aortic valve endocarditis: the mitral kissing vegetation. Eur Heart J 2002;23:79-86.
48. Hujer AM, Bethel CR, Hujer KM, Bonomo RA. Antibiotic resistance in the institutionalized elderly. Clin Lab Med 2004;24:343-361.
49. Zamorano JL, Badano LP, Bruce C, Chan KL, Goncalves A, Hahn RT, KeaneMG, La Canna G, Monaghan MJ, Nihoyannopoulos P, Silvestry FE, Vanoverschelde JL, Gillam LD. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J 2011;32: 2189-2214.
50. Clavel MA, Dumont E, Pibarot P, Doyle D, De Larochelliere R, Villeneuve J, Bergeron S, Couture C, Rodes-Cabau J. Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation. Ann Thorac Surg 2009;87:618-621.
51. Maroto LC, Rodriguez JE, Cobiella J, Silva J. Delayed dislocation of a transapically implanted aortic bioprosthesis. Eur J Cardiothorac Surg 2009;36:935-937.
52. Baumbach H, Hill S, Hansen M, Franke UF. Severe aortic insufficiency after transapical aortic valve implantation. Ann Thorac Surg 2011;92:728-729.
53. Schroeter T, Subramanian S, Lehmann S, Kempfert J, Misfeld M, Mohr FW, Borger MA. Dislocation of a transapically implanted aortic valve prosthesis with a functionally bicuspid aortic valve and ascending aortic aneurysm. Thorac Cardiovasc Surg 2011;59:503-506.
54. Radu C, Raffoul R, Brochet E, Himbert D. Delayed migration of a transfemorally implanted aortic bioprosthesis. J Thorac Cardiovasc Surg 2012;143:e1-e3.
55. Pang PY, Chiam PT, Chua YL, Sin YK. A survivor of late prosthesis migration and rotation following percutaneous transcatheter aortic valve implantation. Eur J Cardiothorac Surg 2012;41:1195-1196.
56. Gul M, Erkanli K, Erol MK, Bakir I. Ventricular embolization of Edwards SAPIEN prosthesis following transcatheter aortic valve implantation. J Invasive Cardiol 2012;24:537-538.
57. Toggweiler S,Wood DA, Rodes-Cabau J, Kapadia S, Willson AB, Ye J, Cheung A, Leipsic J, Binder RK, Gurvitch R, Freeman M, Thompson CR, Svensson LG, Dumont E, Tuzcu EM, Webb JG. Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves. JACC Cardiovasc Interv 2012; 5:571-577.
58. Stangl V, Baldenhofer G, Knebel F, Zhang K, SanadW, Spethmann S, Grubitzsch H, Sander M,Wernecke KD, Baumann G, Stangl K, Laule M. Impact of genderon threemonth outcome and left ventricular remodeling after transfemoral transcatheter aortic valve implantation. Am J Cardiol 2012;110:884-890.
59. Iida R,Welsh RC, Meyer SR, Tyrrell BD, Taylor DA, Shanks M. Pre-dismissal surveillance echocardiography second day after TAVR. JACC Cardiovasc Imaging 2012;5: 1182-1184.
60. Naganuma T, Latib A, Agricola E, Alfieri O, Spagnolo P, Colombo A, Maisano F. Late downward dislocation of a balloon expandable valve into the left ventricular outflow tract following transfemoral transcatheter aortic valve implantation. Circ J 2013;77:1345-1347.
61. Lauten A, Hamadanchi A, Doenst T, Figulla HR. Late migration of balloon-expandable transcatheter aortic valve. Eur Heart J 2013;34:2509.
62. Wendeborn J, Donndorf P,Westphal B, Steinhoff G. Surgical double valve replacement after transcatheter aortic valve implantation and interventional mitral valve repair. Interact Cardiovasc Thorac Surg 2013;17:909-911.
63. Wijesinghe N, Ye J, Rodes-Cabau J, Cheung A, Velianou JL, Natarajan MK, Dumont E, Nietlispach F, Gurvitch R,Wood DA, Tay E,Webb JG. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc Interv 2010;3:1122-1125.
64. Nijhoff F, Agostoni P, Samim M, Ramjankhan FZ, Kluin J, Doevendans PA, Stella PR. Optimisation of transcatheter aortic balloon-expandable valve deployment: the two-step inflation technique. EuroIntervention 2013;9:555-563.
65. Nijhoff F, Agostoni P, Amrane H, Latib A, Testa L, Oreglia JA, De Marco F, Samim M, Bedogni F, Maisano F, Bruschi G, Colombo A, Van Boven AJ, Stella PR. Transcatheter aortic valve implantation in patients with severe aortic valve stenosis and large aortic annulus, using the self-expanding 31-mm Medtronic CoreValve prosthesis: First clinical experience. J Thorac Cardiovasc Surg 2013;01:157-154.
66. Schleger S, Kasel M, Vogel J, Lieber M, Antoni D, Hoffmann E, Eichinger WB. Successful transapical implantation of an Edwards Sapien valve within an insufficient aortic CoreValve prosthesis: an initial experience. Ann Thorac Surg 2013;95: 1070-1072.
67. Pagnotta P, Ferrante G, Presbitero P. Rescue "valve in valve" implantation after late onset corevalve cusp rupture leading to acute massive aortic insufficiency. Catheter Cardiovasc Interv 2014;83:E283-E286.
68. van der LiendenBT, Swinkels BM, Heijmen RH, Mast EG,DeKroonTL,Ten Berg JM. First valve-in-valve direct transaortic CoreValve implantation in an insufficient Sapien valve. JACC Cardiovasc Interv 2011;4:1049-1050.
69. Blumenstein J, Van Linden A, Kim WK, Skwara W, Schoenburg M, Arsalan M, Moellmann H, Niederhagen M, Kempfert J,Walther T. Early SAPIEN transcatheter heart valve dysfunction due to tissue ingrowth in an octogenarian. Clin Res Cardiol 2013;102:237-240.
70. Klotz S, Scharfschwerdt M, Richardt D, Sievers HH. Failed valve-in-valve transcatheter aortic valve implantation. JACC Cardiovasc Interv 2012;5:591-592.
71. Ong SH, Mueller R, Iversen S. Early calcific degeneration of a CoreValve transcatheter aortic bioprosthesis. Eur Heart J 2012;33:586.
72. Hammerstingl C, Nickenig G, Grube E. Treatment of a degenerative stenosed CoreValve(( R)) aortic bioprosthesis by transcatheter valve-in-valve insertion. Catheter Cardiovasc Interv 2012;79:748-755.
73. Hoffmann R, Mollmann H, Lotfi S. Transcatheter aortic valve-in-valve implantation of a corevalve in a degenerated stenotic sapien heart valve prosthesis. Catheter Cardiovasc Interv 2012;82:E922-E925.
74. Kiefer P, Seeburger J, Chu MW, Ender J, Vollroth M, Noack T, Mohr FW, Holzhey DM. Reoperative transapical aortic valve implantation for early structural valve deterioration of a SAPIEN XT valve. Ann Thorac Surg 2013;95:2169-2170.
75. Toggweiler S, Humphries KH, Lee M, Binder RK, Moss RR, Freeman M, Ye J, Cheung A, Wood DA, Webb JG. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol 2013;61:413-419.
76. Thyregod HG, Lund JT, Engstrom T, Steinbruchel DA. Transcatheter aortic valve prosthesis surgically replaced 4 months after implantation. Eur J Cardiothorac Surg 2010;37:494-496.
77. Kiefer P, Lehmkuhl L, Seeburger J, Vollroth M, Noack T, Schroter T, Mohr FW, Holzhey D. Symetis Acurate aortic valve-in-valve implantation for early degeneration of a Sapien THV prosthesis. Ann Thorac Surg 2013;96:1880.
78. Thubrikar MJ, Deck JD, Aouad J, Nolan SP. Role of mechanical stress in calcification of aortic bioprosthetic valves. J Thorac Cardiovasc Surg 1983;86:115-125.
79. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005;79:1072-1080.
80. Manji RA, Zhu LF, Nijjar NK, Rayner DC, Korbutt GS, Churchill TA, Rajotte RV, Koshal A, Ross DB. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 2006;114:318-327.
81. Ruel M, Kulik A, Rubens FD, Bedard P, Masters RG, Pipe AL, Mesana TG. Late incidence and determinants of reoperation in patients with prosthetic heart valves. Eur J Cardiothorac Surg 2004;25:364-370.
82. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 2009;119:1034-1048.
83. Gurvitch R, Wood DA, Tay EL, Leipsic J, Ye J, Lichtenstein SV, Thompson CR, Carere RG, Wijesinghe N, Nietlispach F, Boone RH, Lauck S, Cheung A, Webb JG. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 2010;122: 1319-1327.
84. Sun W, Li K, Sirois E. Simulated elliptical bioprosthetic valve deformation: implications for asymmetric transcatheter valve deployment. J Biomech 2010;43: 3085-3090.
85. Al-Attar N, Himbert D, Vahanian A, Nataf P. Severe intraprosthetic regurgitation by immobile leaflet after trans-catheter aortic valve implantation. Eur J Cardiothorac Surg 2011;39:591-592.
86. Zegdi R, Bruneval P, Blanchard D, Fabiani JN. Evidence of leaflet injury during percutaneous aortic valve deployment. Eur J Cardiothorac Surg 2011;40:257-259.
87. Butany J, Leong SW, Cunningham KS, D'Cruz G, Carmichael K, Yau TM. A 10-year comparison of explanted Hancock-II and Carpentier-Edwards supraannular bioprostheses. Cardiovasc Pathol 2007;16:4-13.
88. Scherner M, Madershahian N, Strauch JT, Wippermann J,Wahlers T. Transapical valve implantation and resuscitation: risk of valve destruction. Ann Thorac Surg 2011;92:1909-1910.
89. Kim EK, Choi SH, Song PS, Park SJ. Valve prosthesis distortion after cardiac compression in a patient who underwent transcatheter aortic valve implantation (TAVI). Catheter Cardiovasc Interv 2012;83:E165-E167.
90. Kirov HM, BotheW, Breuer M, Clasen I, Mall EG, Schluter A, Ferrari M, Doenst T. Deformation of a transapical aortic valve after cardiopulmonary resuscitation: a potential risk of stainless steel stents. J Am Coll Cardiol 2012;60:1838.
91. Damen T, Sunnermalm L, Friberg O, Zagozdzon L, Cederstrand B, Kellert T. Inverted valve after initially successful transfemoral aortic valve implantation. Ann Thorac Surg 2012;94:636-639.
92. Spangenberg T, Frerker C, Bader R, Schafer U. Complete crush of a balloon-expandable bioprosthesis after prolonged cardiopulmonary resuscitation. Circ Cardiovasc Interv 2013;6:e1-e2.
93. Windecker S, MaierW, Eberli FR, Meier B, Hess OM. Mechanical compression of coronary artery stents: potential hazard for patients undergoing cardiopulmonary resuscitation. Catheter Cardiovasc Interv 2000;51:464-467.
94. McElhinney DB, Cheatham JP, Jones TK, Lock JE, Vincent JA, Zahn EM, Hellenbrand WE. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patientrelated and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv 2011;4:602-614.
95. Moreno R, Calvo L, Salinas P, Dobarro D, Santiago JV, Sanchez-Recalde A, Galeote G, Riera L, Moreno-Gomez I, Mesa J, Plaza I, Lopez-Sendon J. Causes of peri-operative mortality after transcatheter aortic valveimplantation: a pooled analysis of 12 studies and 1223 patients. J Invasive Cardiol 2011;23:180-184.
96. Trepels T, Martens S, Doss M, Fichtlscherer S, Schachinger V. Images in cardiovascular medicine. Thrombotic restenosis after minimally invasive implantation of aortic valve stent. Circulation 2009;120:e23-e24.
97. Kefer J, Astarci P, Renkin J, Glineur D, Pierard S, Seldrum S, Vanoverschelde JL. Images and case reports in interventional cardiology. Thrombotic aortic restenosis after transapical Sapien valve implantation. Circ Cardiovasc Interv 2010;3:289-292.
98. Tay EL, Gurvitch R, Wijeysinghe N, Nietlispach F, Wood D, Allard M, Munt B, Cheung A, Webb JG. Valve thrombosis after transcatheter heart valve implantation. EuroIntervention 2011;7:170-171.
99. Latib A, Messika-Zeitoun D, Maisano F, Himbert D, Agricola E, Brochet E, Alfieri O, Colombo A, Vahanian A. Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. J Am Coll Cardiol 2013;61:787-789.
100. Cota L, Stabile E, Agrusta M, Sorropago G, Pucciarelli A, Ambrosini V, Mottola G, Esposito G, Rubino P. Bioprostheses "thrombosis" after transcatheter aortic valve replacement. J Am Coll Cardiol 2013;61:789-791.
101. Greason KL, Mathew V, Sarano ME, Maleszewski JJ, Suri RM, Rihal CS. Early transcatheter aortic valve thrombosis. J Card Surg 2013;28:264-266.
102. Lancellotti P, RadermeckerMA,Weisz SH, LegrandV. Subacute transcatheter CoreValve thrombotic obstruction. Circ Cardiovasc Interv 2013;6:e32-e33.
103. Pache G, Blanke P, ZehW, Jander N. Cusp thrombosis after transcatheter aortic valve replacement detected by computed tomography and echocardiography. Eur Heart J 2013;34:3546.
104. Orbach A, Karkabi B, Shiran A. Reversible restenosis after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 2014;15:350.
105. Pergolini A, Pino PG, Zampi G, Polizzi V, Musumeci F. Thrombotic aortic restenosis after transapical SAPIEN valve implantation. J Card Surg 2014;29:204-208.
106. Puvimanasinghe JP, Steyerberg EW, Takkenberg JJ, Eijkemans MJ, van Herwerden LA, Bogers AJ, Habbema JD. Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation. Circulation 2001;103:1535-1541.
107. Brown ML, Park SJ, Sundt TM, SchaffHV. Early thrombosis risk in patients with biologic valves in the aortic position. J Thorac Cardiovasc Surg 2012;144:108-111.
108. Rodes-Cabau J, Dauerman HL, Cohen MG, Mehran R, Small EM, Smyth SS, Costa MA, Mega JL, O'Donoghue ML, Ohman EM, Becker RC. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. J Am Coll Cardiol 2013;62:2349-2359.
109. Merie C, Kober L, Skov Olsen P, Andersson C, Gislason G, Skov Jensen J, Torp-Pedersen C. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. JAMA 2012;308:2118-2125.
110. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-2496.
111. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM III, Thomas JD. 2014 AHA/ ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:e521-e643.
112. Collet JP, Montalescot G. Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field? EuroIntervention 2013;9(Suppl.):S43-S47.
113. Chikwe J, Filsoufi F, Carpentier AF. Prosthetic valve selection for middle-aged patients with aortic stenosis. Nat Rev Cardiol 2010;7:711-719.
114. Cohn LH, Collins JJ Jr, Rizzo RJ, Adams DH, Couper GS, Aranki SF. Twenty-year follow-up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg 1998;66:S30-S34.
115. David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001;121: 268-277.
116. Mack MJ, Brennan JM, Brindis R, Carroll J, Edwards F, Grover F, Shahian D, Tuzcu EM, Peterson ED, Rumsfeld JS, Hewitt K, Shewan C, Michaels J, Christensen B, Christian A, O'Brien S, Holmes D. Outcomes following transcatheter aortic valve replacement in the United States. JAMA 2013;310:2069-2077.
117. Grunkemeier GL, Jin R, Starr A. Prosthetic heart valves: objective performance criteria versus randomized clinical trial. Ann Thorac Surg 2006;82:776-780.